Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis

BACKGROUND: Stage IV non-small cell lung cancer (NSCLC) is associated with a five-year survival rate of around 1%. Treatment with Viscum album L. (VA) extracts has been shown to reduce chemotherapy (CTx)-related adverse events, decrease CTx dose reductions and improve quality of life in a number of...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Schad, Friedemann, Thronicke, Anja, Steele, Megan L., Merkle, Antje, Matthes, Burkhard, Grah, Christian, Matthes, Harald
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2018
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6110500/
https://ncbi.nlm.nih.gov/pubmed/30148853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0203058
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires